The Use of Palliative Therapy in Patients With Advanced Retroperitoneal Sarcoma
Journal of Surgical Research · 2024
DOI: 10.1016/j.jss.2024.08.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Olivia Monton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Epidemiology, Johns Hopkins Bloomberg School o…. Hauptthemen laut MEDLINE: Palliative Care, Retroperitoneal Neoplasms, Sarcoma. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Advanced retroperitoneal sarcoma (RPS) can include unresectable locoregional disease, systemic or multifocal intra-abdominal metastasis, or abdominal sarcomatosis, all of which are associated with high morbidity and may be addressed through palliative therapy. Current trends in the use of palliative therapy and factors associated with its use in patients with advanced RPS remain largely unexplored. The objectives of this study are to (1) describe the temporal trend in the use of palliative therapy and (2) identify factors associated with its use in patients with advanced RPS in the United States from 2004 to 2020. METHODS: This study is a retrospective cohort study using the National Cancer Database. We identified adult patients who were diagnosed with advanced RPS (American Joint Committee on Cancer stages III and IV) from 2004 to 2020. We performed a trend analysis to describe the use of palliative therapy over time, followed by univariable and multivariable logistic regression analyses to identify predictors of palliative therapy use in this patient population. RESULTS: A total of 6149 patients with advanced RPS were identified, of which only 383 used palliative therapy, including surgery (n = 28), radiation therapy (n = 87), systemic therapy (n = 115), pain management (n = 61), combination therapy (n = 55), or other palliative therapy (n = 37). The proportion of patients using palliative therapy increased significantly from 2.6% in 2004 to 6.5% in 2020 (Ptrend < 0.001). On multivariable logistic regression, age (odds ratio [OR] 1.03, 95 confidence interval [CI] 1.01-1.04), year of diagnosis (OR 1.05, 95 CI 1.02-1.08), lack of insurance (OR 2.18, 95 CI 1.17-4.04), community cancer program status (OR 1.83, 95 CI 1.05-3.19), stage IV disease (OR 5.19, 95 CI 4.49-7.79), and rhabdomyosarcoma (OR 2.75, 95 CI 1.32-5.72) histology were found to be predictors of palliative therapy use. CONCLUSIONS: This study sheds light on the evolving landscape of palliative therapy use for patients with advanced RPS in the United States from 2004 to 2020. The observed gradual increase in the use of palliative therapy underscores the growing recognition of its importance in managing the unique challenges associated with this complex disease. Despite this positive trend, the persistently low overall rates highlight the need for further efforts to enhance awareness and accessibility of palliative therapy for this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Division of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.
- Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
- Division of Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: fjohnst4@jhmi.edu.
Zitieren
APA
Monton, O., Gurau, A., Kopecky, K., Siddiqi, A., Abreha, F. M., Greer, J. B., & Johnston, F. M. (2024). The Use of Palliative Therapy in Patients With Advanced Retroperitoneal Sarcoma. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.08.018
Vancouver
Monton O, Gurau A, Kopecky K, Siddiqi A, Abreha FM, Greer JB, et al. The Use of Palliative Therapy in Patients With Advanced Retroperitoneal Sarcoma. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2024.08.018
BibTeX
@article{Monton2024,
author = {Monton, Olivia and Gurau, Andrei and Kopecky, Kimberly and Siddiqi, Amn and Abreha, Fasika M and Greer, Jonathan B and Johnston, Fabian M},
title = {The Use of Palliative Therapy in Patients With Advanced Retroperitoneal Sarcoma},
journal = {Journal of Surgical Research},
year = {2024},
doi = {10.1016/j.jss.2024.08.018}
}
EUVIMED